Anticancer potential of NSAID-derived tris(pyrazolyl)methane ligands in iron(II) sandwich complexes

Tris(pyrazolyl)methane (tpm), 2,2,2-tris(pyrazolyl)ethanol (tpmOH) and its esterification derivatives with ibuprofen and flurbiprofen (tpmIBU and tpmFLU) were used as ligands to obtain complexes of the type [Fe(tpmX)2]Cl2 (1-4). The tpmIBU and tpmFLU ligands and corresponding complexes 3 and 4 were characterized by IR and multinuclear NMR spectroscopy, and the structure of tpmIBU was elucidated by single crystal X-ray diffraction. Complexes 1-4 were also assessed for their behaviour in aqueous media (solubility in D2O, octanol/water partition coefficient, stability in physiological-like conditions). The antiproliferative activity of ligands and complexes was determined on A2780, A2780cis and A549 cancer cell lines and the non-cancerous HEK 293T and BJ cell lines. The ligands and complexes were investigated for their ability to inhibit COX-2 (cyclooxygenase) and HNE (4-hydroxynonenal) enzymes. Complexes 3 and 4 exhibited cytotoxicity that may be attributed predominantly to their bioactive fragments, while DNA binding and enhancement of ROS production do not appear to play any significant role.

Hexakispyrazolylethane: New Strategy for Stabilization of Hexaarylethane

Hexakis(4-trimethylsilylpyrazol-1-yl)ethane was synthesized by the oxidative dimerization of tris(4-trimethylsilylpyrazol-1-yl)methane. Single-crystal X-ray structural analysis of hexakis(4-trimethylsilylpyrazol-1-yl)ethane showed that the ethane C-C bond (1.623(4) Å) is shorter than that in hexaphenylethane (1.67(3) Å). In solution, hexakis(4-trimethylsilylpyrazol-1-yl)ethane existed as a single species, contrastive that conventional hexaphenylethanes can keep the central C-C bond only by the aid of additional bridges between the two triarylmethyl units. Theoretical calculations indicated that the tris(pyrazol-1-yl)methyl radical, which is anticipated to be under equilibrium with hexakis(pyrazol-1-yl)ethane, is less stable than trityl radicals due to lack of delocalization of the radicals. Furthermore, introduction of pyrazole groups allowed additional bridging between the two triarylmethyl moieties through metal coordination to the adjacent N atoms: hexakis(4-trimethylsilylpyrazol-1-yl)ethane exhibited unique coordination to three Ag atoms affording a hexaarylethane analog bearing three N-Ag-N bridges.

Ruthenium(II)-Tris-pyrazolylmethane Complexes Inhibit Cancer Cell Growth by Disrupting Mitochondrial Calcium Homeostasis

While ruthenium arene complexes have been widely investigated for their medicinal potential, studies on homologous compounds containing a tridentate tris(1-pyrazolyl)methane ligand are almost absent in the literature. Ruthenium(II) complex 1 was obtained by a modified reported procedure; then, the reactions with a series of organic molecules (L) in boiling alcohol afforded novel complexes 2–9 in 77–99% yields. Products 2–9 were fully structurally characterized. They are appreciably soluble in water, where they undergo partial chloride/water exchange. The antiproliferative activity was determined using a panel of human cancer cell lines and a noncancerous one, evidencing promising potency of 1, 7, and 8 and significant selectivity toward cancer cells. The tested compounds effectively accumulate in cancer cells, and mitochondria represent a significant target of biological action. Most notably, data provide convincing evidence that the mechanism of biological action is mediated by the inhibiting of mitochondrial calcium intake.

Novel Chemotherapeutic Agents - The Contribution of Scorpionates

The development of safe and effective chemotherapeutic agents is one of the uppermost priorities and challenges of medicinal chemistry and new transition metal complexes are being continuously designed and tested as anticancer agents. Scorpionate ligands have played a great role in coordination chemistry, since their discovery by Trofimenko in the late 1960s, with significant contributions in the fields of catalysis and bioinorganic chemistry. Scorpionate metal complexes have also shown interesting anticancer properties, and herein, the most recent (last decade) and relevant scorpionate complexes reported for application in medicinal chemistry as chemotherapeutic agents are reviewed. The current progress on the anticancer properties of transition metal complexes bearing homo- or hetero- scorpionate ligands, derived from bis- or tris-(pyrazol-1-yl)-borate or -methane moieties is highlighted.

Phosphine-functionalised tris(pyrazolyl)methane ligands and their mono- and heterobimetallic complexes

The synthesis, characterisation and reactivity of new phosphine-functionalised tris(pyrazolyl)methane ligands (TpmPR₂, 2a-c, with R = Ph, nBu, iPr) are presented. The reaction of 2a-c with [Rh(CO)₂Cl]₂ furnished N,P-heterochelate carbonyl complexes (3a-c), which were used to quantify the donor abilities of the ligands via IR spectroscopy. The coordination flexibility was demonstrated by treating representative members of this new ligand class with [CpRu(acn)₃][PF₆] (acn = acetonitrile), [(tht)AuCl] (tht = tetrahydrothiophene) and [Pd(allyl)Cl]₂ providing either a N,N,P-heteroscorpionate complex (4) or the P-coordinated complexes (5,6) without any involvement of the pyrazolyl entities. With 2a and [Pd(cod)Cl₂], another P,N-heterochelate complex (7) was obtained, which served as a precursor for a heterobimetallic complex containing palladium and copper (8). Detailed NMR spectroscopic and X-ray crystallographic investigations have been performed on all new complexes.

Group 11 tris(pyrazolyl)methane complexes: structural features and catalytic applications

Tris(pyrazolyl)methane ligands (Tpm^x) have been for years a step behind their highly popular boron-anionic analogues, the tris(pyrazolyl)borate ligands (Tp^x).

Multiple coordination modes of a new ditopic bis(pyrazolyl)methane-based ligand

A new ditopic ligand, N-(2,2-bis(pyrazolyl)ethyl)-2,2-bis(pyrazolyl)acetamide ((pz)₂CH-C(O)-NH-CH₂-CH(pz)₂, L4Pz, pz = pyrazolyl ring), comprising two bis(pyrazolyl)methane donor groups linked via an amide bridge, has been prepared from the reaction of HOOCCH(pz)₂ and H₂NCH₂CH(pz)₂. The ligand coordinates to various metallic salts (i.e. AgO₃SCF₃, PdCl₂, Re(CO)₅Br, and Fe(BF₄)₂), in either a κ²-μ-κ² or a κ³-μ-κ² fashion, depending on the coordination preferences of the metallic center. These compounds were characterized by NMR, UV-Vis and IR spectroscopy, and in solid state by single crystal X-ray diffraction. In the case of silver(i), a mono-dimensional coordination polymer was obtained, while the others were found to be discrete complexes. The synthesis and characterization of a heterobimetallic complex is also described. In solid state, all compounds are associated into supramolecular architectures via hydrogen bonding and pyrazolyl embrace interactions.

Reaction Chemistry of Silver(I) Trifluoromethanesulfonate Complexes of Nitrogen-Confused C-Scorpionates

Two new C-scorpionate ligands with a bis(3,5-dimethylpyrazol-1-yl)methyl group bound to the 3 position of either an N-tosyl (^TsL*) or an N-H pyrazole (^HL*) ring have been prepared. The silver(I) complexes of these new ligands and the two previously reported analogous ligands with unsubstituted bis(pyrazol-1-yl)methyl groups (^TsL and ^HL) in both 1:1 and 2:1 ligand/metal ratios were investigated to explore the effects of ligand sterics on their physical and chemical properties. The structurally characterized derivatives of the type [Ag(L)₂](OTf) are four-coordinate, where the confused pyrazolyl is not bound to the metal. On the other hand, three 1:1 complexes [Ag(L)](OTf) had all pyrazolyls bound, while the μ-κ¹,κ¹-^TsL derivative had an unbound confused pyrazolyl. The molecularity of the latter four ranged from polymeric to dimeric to monomeric in the solid with increasing steric bulk of the ligand. The utility of these complexes in stoichiometric ligand-transfer reactions and in styrene aziridination was demonstrated. Thus, tricarbonylmanganese(I) complexes were prepared as kinetically inert models for comparative solution diffusion NMR studies. Also, [Fe(^HL)₂](OTf)₂ was prepared for similar reasons and to compare the effects of anion on spin-crossover properties.

Synthesis and crystal structures of three new benzotriazolylpropanamides

The base-catalyzed Michael addition of 2-methyl-acryl-amide to benzotriazole afforded 3-(1H-benzotriazol-1-yl)-2-methyl-propanamide, C10H12N4O (1), in 32% yield in addition to small amounts of isomeric 3-(2H-benzotriazol-2-yl)-2-methyl-propanamide, C10H12N4O (2). In a similar manner, 3-(1H-benzotriazol-1-yl)-N,N-di-methyl-propanamide, C11H14N4O (3), was prepared from benzotriazole and N,N-di-methyl-acryl-amide. All three products have been structurally characterized by single-crystal X-ray diffraction. The crystal structures of 1 and 2 comprise infinite arrays formed by N-H⋯O and N-H⋯N bridges, as well as π-π inter-actions, while the mol-ecules of 3 are aggregated to simple π-dimers in the crystal.

Solventless Synthesis of Poly(pyrazolyl)phenyl-methane Ligands and Thermal Transformation of Tris(3,5-dimethylpyrazol-1-yl)phenylmethane

The solventless synthesis of tris(pyrazolyl)phenylmethane ligands of formula C₆H₅C(Pz^R2)₃ (R = H, Me), starting from PhCCl₃ and 3,5-dimethylpyrazole (Pz^Me2) or pyrazole (Pz) was performed. The sterically crowded C₆H₅C(Pz^Me2)₃ is thermally transformed into the bis(pyrazolyl)(p-pyrazolyl)phenylmethane ligand Pz^Me2-C₆H₄CH(Pz^Me2)₂. In this compound both Pz^Me2 rings are linked through the N-atom to the methine C-atom. At higher temperatures, the binding mode of Pz^Me2 changes from N1 to C4. All transformations occurred via quinonoid carbocation intermediates that undergo an aromatic electrophilic substitution on the 4-position of Pz^Me2. Reaction conditions were established to obtain five tris(pyrazolyl)phenylmethane ligands in moderate to good yields. ¹H- and ¹³C-NMR spectroscopy and X-ray diffraction of single crystals support the proposed structures.

Silver(I) and rhenium(I) metal complexes of a 2,2′-bipyridine-functionalized third-generation tris(pyrazolyl)methane ligand

Heterotopic ligands offer the possibility of preparing polynuclear bimetallic complexes. Recent studies of heteroditopic ligands and their metal complexes have focused on novel supramolecular systems, biological activity, and the development of MRI contrast agents. The heteroditopic ligand Bipy–CH2–O–CH2–C(pz)3(Bipy-L; Bipy is 2,2′-bipyridine and pz is pyrazolyl) reacts with AgBF4to produce the coordination polymercatena-poly[[silver(I)-(μ-5-{[tris(pyrazol-1-yl)methoxy]methyl-κ2N,N′}-2,2′-bipyridine-κ2N,N′)] diethyl ether hemisolvate], {[Ag(C22H20N8O)]BF4·0.5C4H10O}n, and with Re(CO)5Br to form the discrete compound bromidotricarbonyl(5-{[tris(pyrazol-1-yl)methoxy]methyl}-2,2′-bipyridine-κ2N,N′)rhenium(I), [ReBr(C22H20N8O)(CO)3]. The silver(I) compound is a one-dimensional coordination polymer, built up by a κ2coordination mode of the bipyridine group and a κ2–κ0coordination mode of the –C(pz)3donor set. In [ReBr(Bipy-L)(CO)3], the ligand coordinates onlyviathe bipyridine end, leaving the –C(pz)3donor set free for further coordination interactions.

A family of complexes with N-scorpionate-type and other N-donor ligands obtained in situ from pyrazole derivative and zerovalent cobalt. Physicochemical and cytotoxicity studies

In this paper we described one pot synthetic pathways which generated in situ three complexes which contain three different ligands: N,N,N-tris(3,5-dimethylpyrazolylmethyl)amine (L¹), urotropine (L²) and 3,5-dimethylpyrazole (L³).